Capital International Investors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510M Sell
3,399,604
-81,714
-2% -$8.89M 0.11% 149
2026
Q1
$322M Sell
3,481,318
-47,338
-1% -$4.75M 0.08% 183
2025
Q4
$360M Sell
3,528,656
-1,160,585
-25% -$104M 0.06% 197
2025
Q3
$293M Sell
4,689,241
-287,217
-6% -$15.6M 0.05% 206
2025
Q2
$259M Sell
4,976,458
-171,266
-3% -$7.65M 0.04% 212
2025
Q1
$219M Buy
5,147,724
+674,482
+15% +$29.1M 0.04% 212
2024
Q4
$137M Hold
4,473,242
0.03% 259
2024
Q3
$103M Buy
4,473,242
+4,519
+0.1% +$128K 0.02% 271
2024
Q2
$129M Buy
4,468,723
+645,784
+17% +$15M 0.03% 244
2024
Q1
$78.9M Sell
3,822,939
-178,864
-4% -$3.83M 0.02% 295
2023
Q4
$108M Buy
4,001,803
+1,074,452
+37% +$28.2M 0.02% 275
2023
Q3
$86.8M Buy
2,927,351
+32,307
+1% +$1.14M 0.02% 283
2023
Q2
$104M Sell
2,895,044
-4,329,827
-60% -$124M 0.03% 283
2023
Q1
$169M Sell
7,224,871
-627,036
-8% -$17.9M 0.04% 248
2022
Q4
$214M Buy
7,851,907
+1,697,998
+28% +$77.7M 0.06% 231
2022
Q3
$331M Buy
6,153,909
+576,044
+10% +$29.6M 0.1% 191
2022
Q2
$225M Buy
5,577,865
+496,241
+10% +$24.6M 0.06% 235
2022
Q1
$337M Buy
5,081,624
+2,110,240
+71% +$144M 0.08% 215
2021
Q4
$297M Buy
2,971,384
+818,309
+38% +$84.6M 0.06% 232
2021
Q3
$269M Buy
2,153,075
+159,413
+8% +$18.9M 0.06% 234
2021
Q2
$248M Buy
1,993,662
+213,308
+12% +$28.7M 0.06% 230
2021
Q1
$272M Buy
1,780,354
+284,652
+19% +$43M 0.07% 212
2020
Q4
$193M Buy
+1,495,702
New +$172M 0.05% 239

Other funds holding GH

Capital International Investors's GH Position: Q2 2026 in Review

Capital International Investors reduced its Guardant Health (GH) stake by 2.3% in Q2 2026, selling an estimated $8.89M and leaving 3,399,604 shares worth $510M. The position accounts for 0.11% of the portfolio, ranked #149.

Capital International Investors first reported a position in GH in Q4 2020 and has held it in 23 quarters since. 425 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Capital International Investors held 3,399,604 shares of Guardant Health worth $510M as of Q2 2026.
  • Capital International Investors sold 81,714 Guardant Health shares in Q2 2026, an estimated $8.89M.
  • Guardant Health made up 0.11% of Capital International Investors's portfolio in Q2 2026, its #149 holding.
  • Capital International Investors first reported a position in Guardant Health in Q4 2020 and has held it in 23 quarters since.
  • 425 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.